For example, Zhang et al. suggested UBE2C as a prognostic marker and a promising therapeutic target in gastric cancer [26], and Li et al. reported UBE2C as a prognostic biomarker and a potential therapeutic target associated with chemo–resistance in ovarian cancer [27]. The gene discussed is UBE2C; the disease is ovarian carcinoma.